Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
3,073
-91
-3% -$10.3K 0.12% 110
2025
Q4
$396K Buy
3,164
+5
+0.2% +$637 0.16% 95
2025
Q3
$423K Sell
3,159
-29
-0.9% -$3.81K 0.18% 94
2025
Q2
$434K Sell
3,188
-8
-0.3% -$1.05K 0.2% 91
2025
Q1
$424K Buy
3,196
+75
+2% +$9.54K 0.21% 86
2024
Q4
$353K Sell
3,121
-684
-18% -$79K 0.18% 95
2024
Q3
$434K Buy
3,805
+95
+3% +$10.4K 0.21% 83
2024
Q2
$386K Buy
3,710
+86
+2% +$9.12K 0.2% 85
2024
Q1
$412K Buy
3,624
+154
+4% +$17.7K 0.21% 85
2023
Q4
$382K Buy
3,470
+44
+1% +$4.4K 0.21% 86
2023
Q3
$332K Buy
3,426
+120
+4% +$12.6K 0.2% 82
2023
Q2
$360K Buy
3,306
+104
+3% +$11.1K 0.22% 81
2023
Q1
$324K Hold
3,202
0.2% 90
2022
Q4
$352K Sell
3,202
-10
-0.3% -$1.03K 0.23% 86
2022
Q3
$311K Hold
3,212
0.23% 87
2022
Q2
$349K Sell
3,212
-50
-2% -$5.68K 0.24% 85
2022
Q1
$386K Hold
3,262
0.24% 94
2021
Q4
$459K Buy
3,262
+700
+27% +$89.6K 0.28% 84
2021
Q3
$303K Buy
2,562
+28
+1% +$3.44K 0.22% 100
2021
Q2
$294 Hold
2,534
0.14% 102
2021
Q1
$304 Buy
+2,534
New +$300K 0.17% 98

Other funds holding ABT

MBA Advisors's ABT Position: Q1 2026 in Review

MBA Advisors reduced its Abbott (ABT) stake by 2.9% in Q1 2026, selling an estimated $10.3K and leaving 3,073 shares worth $316K. The position accounts for 0.12% of the portfolio, ranked #110.

MBA Advisors first reported a position in ABT in Q1 2021 and has held it in 21 quarters since. The position peaked at $459K in Q4 2021. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • MBA Advisors held 3,073 shares of Abbott worth $316K as of Q1 2026.
  • MBA Advisors sold 91 Abbott shares in Q1 2026, an estimated $10.3K.
  • Abbott made up 0.12% of MBA Advisors's portfolio in Q1 2026, its #110 holding.
  • MBA Advisors first reported a position in Abbott in Q1 2021 and has held it in 21 quarters since.
  • MBA Advisors's Abbott position peaked at $459K in Q4 2021.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.